4//SEC Filing
D'Silva Andrew J. 4
Accession 0001628280-25-050744
CIK 0001448431other
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 5:51 PM ET
Size
6.6 KB
Accession
0001628280-25-050744
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
D'Silva Andrew J.
Chief Business Officer
Transactions
- Tax Payment
Common Stock
2025-10-01$18.98/sh−414$7,858→ 47,100 total - Tax Payment
Common Stock
2025-10-03$18.75/sh−794$14,888→ 46,306 total
Footnotes (1)
- [F1]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0002083717
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 5:51 PM ET
- Size
- 6.6 KB